A detailed history of Cullen/Frost Bankers, Inc. transactions in Hologic Inc stock. As of the latest transaction made, Cullen/Frost Bankers, Inc. holds 2,772 shares of HOLX stock, worth $198,807. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,772
Previous 2,822 1.77%
Holding current value
$198,807
Previous $209,000 7.66%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$73.48 - $83.64 $3,674 - $4,182
-50 Reduced 1.77%
2,772 $225,000
Q2 2024

Aug 05, 2024

BUY
$71.43 - $78.41 $2,500 - $2,744
35 Added 1.26%
2,822 $209,000
Q4 2023

Feb 06, 2024

SELL
$65.11 - $72.63 $12,761 - $14,235
-196 Reduced 6.57%
2,787 $199,000
Q2 2023

Aug 04, 2023

BUY
$77.76 - $87.67 $1,555 - $1,753
20 Added 0.67%
2,983 $241,000
Q4 2022

Feb 13, 2023

BUY
$61.6 - $76.99 $107,984 - $134,963
1,753 Added 144.88%
2,963 $221,000
Q3 2022

Nov 07, 2022

BUY
$62.71 - $73.47 $877 - $1,028
14 Added 1.17%
1,210 $78,000
Q1 2022

May 09, 2022

SELL
$68.08 - $76.82 $119,344 - $134,665
-1,753 Reduced 59.44%
1,196 $92,000
Q4 2021

Feb 07, 2022

BUY
$68.97 - $77.92 $120,904 - $136,593
1,753 Added 146.57%
2,949 $226,000
Q2 2021

Aug 05, 2021

BUY
$60.52 - $76.68 $60,520 - $76,680
1,000 Added 510.2%
1,196 $80,000
Q1 2021

May 05, 2021

SELL
$68.76 - $83.72 $1,375 - $1,674
-20 Reduced 9.26%
196 $15,000
Q3 2020

Nov 05, 2020

SELL
$56.85 - $73.32 $98,521 - $127,063
-1,733 Reduced 88.92%
216 $14,000
Q2 2020

Aug 05, 2020

BUY
$32.7 - $57.0 $57,323 - $99,921
1,753 Added 894.39%
1,949 $111,000
Q2 2019

Aug 01, 2019

SELL
$43.0 - $49.21 $860 - $984
-20 Reduced 9.26%
196 $9,000
Q1 2019

Apr 30, 2019

BUY
$38.28 - $48.4 $8,268 - $10,454
216 New
216 $10,000

Others Institutions Holding HOLX

About HOLOGIC INC


  • Ticker HOLX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 249,652,992
  • Market Cap $17.9B
  • Description
  • Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The...
More about HOLX
Track This Portfolio

Track Cullen/Frost Bankers, Inc. Portfolio

Follow Cullen/Frost Bankers, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cullen/Frost Bankers, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cullen/Frost Bankers, Inc. with notifications on news.